Close

Interpace Diagnostics (IDXG) Reports New CPT Code for Reimbursement of Molecular Thyroid Test

September 11, 2017 8:07 AM EDT Send to a Friend
Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically useful molecular ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login